| scholarly article | Q13442814 |
| P50 | author | Claire N McBrien | Q57305810 |
| P2093 | author name string | Andrew Menzies-Gow | |
| P2860 | cites work | Disordered microbial communities in asthmatic airways | Q21562589 |
| Epithelial-derived TGF-beta2 modulates basal and wound-healing subepithelial matrix homeostasis | Q24299083 | ||
| Substrates and products of eosinophil peroxidase | Q24533401 | ||
| Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis | Q24629044 | ||
| Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion | Q24676901 | ||
| Evaluation and differential diagnosis of marked, persistent eosinophilia | Q27001673 | ||
| Pattern recognition receptors and inflammation | Q27861115 | ||
| Interleukin-13 induces PSGL-1/P-selectin-dependent adhesion of eosinophils, but not neutrophils, to human umbilical vein endothelial cells under flow | Q28144287 | ||
| Pharmacology of the eosinophil | Q28198022 | ||
| Novel combinatorial interactions of GATA-1, PU.1, and C/EBPepsilon isoforms regulate transcription of the gene encoding eosinophil granule major basic protein | Q28219413 | ||
| Eosinophil cationic protein stimulates migration of human lung fibroblasts in vitro | Q28238081 | ||
| The cytotoxicity of eosinophil cationic protein/ribonuclease 3 on eukaryotic cell lines takes place through its aggregation on the cell membrane | Q28261412 | ||
| Eosinophil cationic protein high-affinity binding to bacteria-wall lipopolysaccharides and peptidoglycans | Q28269724 | ||
| A review on leukotrienes and their receptors with reference to asthma | Q28294597 | ||
| Non-eosinophilic asthma: importance and possible mechanisms | Q28394141 | ||
| Eosinophilic Inflammation in Asthma | Q29031455 | ||
| The biology of chemokines and their receptors | Q29619170 | ||
| Macrophage activation and polarization: nomenclature and experimental guidelines | Q29620642 | ||
| Eosinophil granules function extracellularly as receptor-mediated secretory organelles | Q30484748 | ||
| Human eosinophils secrete preformed, granule-stored interleukin-4 through distinct vesicular compartments. | Q30489042 | ||
| Rapid mobilization of intracellularly stored RANTES in response to interferon-gamma in human eosinophils | Q30724124 | ||
| Selective depletion of eosinophils or neutrophils in mice impacts the efficiency of apoptotic cell clearance in the thymus | Q33631147 | ||
| IgE, mast cells, basophils, and eosinophils | Q33760398 | ||
| Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation | Q33761299 | ||
| Eosinophils as antigen-presenting cells in allergic upper airway disease | Q33834649 | ||
| Fundamental signals that regulate eosinophil homing to the gastrointestinal tract | Q33853251 | ||
| Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor | Q33894905 | ||
| Airway surface mycosis in chronic TH2-associated airway disease. | Q33993743 | ||
| IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines | Q34090258 | ||
| Airway remodelling in asthma: from benchside to clinical practice | Q34105688 | ||
| Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni | Q45018920 | ||
| Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial | Q45297326 | ||
| Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. | Q45755848 | ||
| Role of atopic status in Toll-like receptor (TLR)7- and TLR9-mediated activation of human eosinophils | Q46171837 | ||
| Eosinophilic airway inflammation in asthmatic patients is associated with an altered airway microbiome | Q46438073 | ||
| Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial | Q47249808 | ||
| Increased eosinophil-lineage committed progenitors in the lung of allergen-challenged mice | Q47869342 | ||
| A critical role for eosinophils in allergic airways remodeling | Q47925478 | ||
| Defining a link with asthma in mice congenitally deficient in eosinophils. | Q47925494 | ||
| Mepolizumab treatment in patients with severe eosinophilic asthma | Q48065984 | ||
| The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein X. | Q48877741 | ||
| Mechanisms of human eosinophil activation by complement protein C5a and platelet-activating factor: similar functional responses are accompanied by different morphologic alterations | Q49246829 | ||
| IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors. | Q50861647 | ||
| Inhibition of nerve growth factor/tyrosine kinase receptor A signaling ameliorates airway remodeling in chronic allergic airway inflammation. | Q51006781 | ||
| Eosinophils are required for the maintenance of plasma cells in the bone marrow. | Q51024387 | ||
| HB-EGF-Promoted Airway Smooth Muscle Cells and Their Progenitor Migration Contribute to Airway Smooth Muscle Remodeling in Asthmatic Mouse. | Q51551147 | ||
| Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone-dependent severe asthma. | Q51563764 | ||
| IL-17A, but not IL-17F, is indispensable for airway vascular remodeling induced by exaggerated Th17 cell responses in prolonged ovalbumin-challenged mice. | Q51649301 | ||
| Airway structural alterations selectively associated with severe asthma. | Q51690348 | ||
| Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. | Q51699006 | ||
| Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. | Q51699174 | ||
| Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues: potential role in capillary branching. | Q51786158 | ||
| Eosinophils: biological properties and role in health and disease. | Q51960619 | ||
| CD11c+ eosinophils in the murine thymus: developmental regulation and recruitment upon MHC class I-restricted thymocyte deletion. | Q52166318 | ||
| Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. | Q55034563 | ||
| Prednisone-dependent asthma: inflammatory indices in induced sputum | Q57415818 | ||
| Leukotrienes and Prostaglandins in Asthma | Q57638537 | ||
| The Relationship Between Allergen-Induced Tissue Eosinophilia and Markers of Repair and Remodeling in Human Atopic Skin | Q57966311 | ||
| MEDI-563, a humanized anti–IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function | Q60632052 | ||
| Hierarchy of eosinophil chemoattractants: role of p38 mitogen-activated protein kinase | Q60734268 | ||
| Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense | Q61959753 | ||
| Mast Cell and Eosinophil Distribution and Activation in Human Endometrium throughout the Menstrual Cycle1 | Q61989613 | ||
| Eosinophils from patients with blood eosinophilia express transforming growth factor beta 1 | Q67715407 | ||
| Comparison of airway and blood eosinophil function after in vivo antigen challenge | Q67887085 | ||
| Eosinophil cationic protein alters proteoglycan metabolism in human lung fibroblast cultures | Q68003083 | ||
| Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma | Q68052191 | ||
| Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to a distinct crystalloid-free granule population in mature human eosinophils | Q69031879 | ||
| Nerve growth factor prevents apoptosis of rat peritoneal mast cells through the trk proto-oncogene receptor | Q70837508 | ||
| Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation | Q71540543 | ||
| Eosinophilic inflammation is associated with elevation of interleukin-5 in the airways of patients with spontaneous symptomatic asthma | Q71586532 | ||
| Increased levels of CD34+ hemopoietic progenitor cells in atopic subjects | Q71778422 | ||
| Human eosinophils stimulate DNA synthesis and matrix production in dermal fibroblasts | Q72854483 | ||
| Effects of TNF-alpha, IFN-gamma and IL-beta on normal human bronchial epithelial cells | Q72998977 | ||
| Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics | Q73202075 | ||
| Involvement of complement and fibronectin in eosinophil-mediated damage to Nippostrongylus brasiliensis larvae | Q73341467 | ||
| Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis | Q73431447 | ||
| Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis | Q73651422 | ||
| Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow | Q74357254 | ||
| Eosinophil infiltration and degranulation in normal human tissue | Q77539954 | ||
| Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis | Q77660836 | ||
| CD34(+)/interleukin-5Ralpha messenger RNA+ cells in the bronchial mucosa in asthma: potential airway eosinophil progenitors | Q77742474 | ||
| Ablation of eosinophils leads to a reduction of allergen-induced pulmonary pathology | Q78396719 | ||
| Early thickening of the reticular basement membrane in children with difficult asthma | Q78719252 | ||
| Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils | Q79856676 | ||
| The IL-3/IL-5/GM-CSF common receptor plays a pivotal role in the regulation of Th2 immunity and allergic airway inflammation | Q80455192 | ||
| The role of complement in innate, adaptive and eosinophil-dependent immunity to the nematode Nippostrongylus brasiliensis | Q80735385 | ||
| Role of selectins in the intestinal epithelial migration of eosinophils | Q81272388 | ||
| Generation of Th1 and Th2 chemokines by human eosinophils: evidence for a critical role of TNF-alpha | Q81317318 | ||
| Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway | Q81672236 | ||
| Antigen-Specific IgG and IgA, but Not IgE, Activate the Effector Functions of Eosinophils in the Presence of Antigen | Q84792417 | ||
| Eosinophils induce airway smooth muscle cell proliferation | Q85526923 | ||
| Platelet activating factor in allergies | Q86524237 | ||
| Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates | Q34185442 | ||
| Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein | Q34189784 | ||
| Human eosinophil-granule major basic protein and synthetic polycations induce airway hyperresponsiveness in vivo dependent on bradykinin generation | Q34209721 | ||
| Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia | Q34230967 | ||
| Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. | Q34430916 | ||
| Systemic side effects of inhaled corticosteroids in patients with asthma | Q34484565 | ||
| The expanding role(s) of eosinophils in health and disease | Q34641880 | ||
| Eosinophil inversely associates with type 2 diabetes and insulin resistance in Chinese adults | Q34872477 | ||
| Eosinophils: changing perspectives in health and disease | Q35170969 | ||
| The regulation of immunoglobulin E class-switch recombination | Q35209475 | ||
| Purification of human eosinophil-derived neurotoxin | Q35468177 | ||
| Topographical continuity of bacterial populations in the healthy human respiratory tract | Q35528519 | ||
| A defective type 1 response to rhinovirus in atopic asthma. | Q35535100 | ||
| Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). | Q35602823 | ||
| Expression and activation of TGF-beta isoforms in acute allergen-induced remodelling in asthma | Q35844179 | ||
| Nerve growth factor and its receptors in asthma and inflammation | Q35908608 | ||
| Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics | Q36001230 | ||
| Eosinophil crystalloid granules: structure, function, and beyond | Q36091297 | ||
| The role of eosinophils in the pathogenesis of asthma | Q36095350 | ||
| Refining the definition of hypereosinophilic syndrome | Q36103687 | ||
| Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo | Q36369717 | ||
| Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus | Q36403355 | ||
| Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta) | Q36429520 | ||
| IL-13 induces a bronchial epithelial phenotype that is profibrotic | Q36537810 | ||
| IL-5 drives eosinophils from bone marrow to blood and tissues in a guinea-pig model of visceral larva migrans syndrome | Q36628083 | ||
| Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions | Q36655884 | ||
| IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand | Q36696547 | ||
| The regulatory role of TGF-beta in airway remodeling in asthma | Q36746333 | ||
| Eosinophil trafficking in allergy and asthma. | Q36811728 | ||
| Eosinophils in innate immunity: an evolving story | Q36921021 | ||
| Eosinophils secrete IL-4 to facilitate liver regeneration | Q36932394 | ||
| Up-regulation and activation of eosinophil integrins in blood and airway after segmental lung antigen challenge | Q36980346 | ||
| Interaction between allergy and innate immunity: model for eosinophil regulation of epithelial cell interferon expression | Q37003801 | ||
| The role of the complement anaphylatoxins in the recruitment of eosinophils | Q37015015 | ||
| Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade | Q37144437 | ||
| Lymph node trafficking and antigen presentation by endobronchial eosinophils | Q37176309 | ||
| IDO: a double-edged sword for T(H)1/T(H)2 regulation | Q37281950 | ||
| Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation | Q37374729 | ||
| Biology of the eosinophil | Q37397520 | ||
| Thymic indoleamine 2,3-dioxygenase-positive eosinophils in young children: potential role in maturation of the naive immune system | Q37413688 | ||
| An update on the role of leukotrienes in asthma | Q37633331 | ||
| Mepolizumab and exacerbations of refractory eosinophilic asthma | Q37711391 | ||
| Eosinophils in health and disease: the LIAR hypothesis | Q37743621 | ||
| Eosinophil granule proteins: form and function | Q38209847 | ||
| Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor | Q38361721 | ||
| The Eosinophil in Infection | Q38675311 | ||
| Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial | Q39408906 | ||
| The eosinophil and the pathophysiology of asthma | Q39730322 | ||
| Bactericidal action of eosinophils from normal human blood | Q40161332 | ||
| Eosinophil-derived cationic proteins activate the synthesis of remodeling factors by airway epithelial cells | Q40230341 | ||
| Estimation of kinetic parameters of neutrophilic, eosinophilic, and basophilic granulocytes in human blood | Q40243844 | ||
| Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study | Q40401116 | ||
| Tumor necrosis factor-alpha induces transforming growth factor-beta1 expression in lung fibroblasts through the extracellular signal-regulated kinase pathway. | Q40470243 | ||
| Cutting edge: human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase | Q40495420 | ||
| Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production | Q40849898 | ||
| Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. | Q41021385 | ||
| Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials | Q41452053 | ||
| The immunology of asthma | Q41673436 | ||
| Requirement for IL-13 independently of IL-4 in experimental asthma | Q41881960 | ||
| Transforming growth factor-beta induces airway smooth muscle hypertrophy | Q42005944 | ||
| Human airway smooth muscle promotes eosinophil differentiation | Q42170514 | ||
| Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. | Q42258225 | ||
| Eosinophils in the human corpus luteum: the role of RANTES and eotaxin in eosinophil attraction into periovulatory structures | Q42496740 | ||
| A novel CC-chemokine receptor 3 antagonist, Ki19003, inhibits airway eosinophilia and subepithelial/peribronchial fibrosis induced by repeated antigen challenge in mice | Q43172485 | ||
| 2.5S nerve growth factor enhances survival, phagocytosis, and superoxide production of murine neutrophils | Q43882347 | ||
| Eosinophil major basic protein activates human cord blood mast cells primed with fibroblast membranes by integrin-β1. | Q43969556 | ||
| Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. | Q44247874 | ||
| Eosinophil Major Basic Protein Stimulates Neutrophil Superoxide Production by a Class IA Phosphoinositide 3-Kinase and Protein Kinase C-ζ-Dependent Pathway | Q44590783 | ||
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 93 | |
| P577 | publication date | 2017-06-30 | |
| P1433 | published in | Frontiers in Medicine | Q27726181 |
| P1476 | title | The Biology of Eosinophils and Their Role in Asthma | |
| P478 | volume | 4 |
| Q61807285 | Analysis of the predicting factors of recurrent wheezing in infants |
| Q55004171 | Benralizumab in the treatment of severe asthma: design, development and potential place in therapy. |
| Q55003087 | Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma. |
| Q91988288 | Bioinformatic analysis of eosinophil activity and its implications for model and target species |
| Q89027053 | Characterization of Siglec-8 Expression on Lavage Cells after Segmental Lung Allergen Challenge |
| Q93147066 | Comparison of IL-33 and IL-5 family mediated activation of human eosinophils |
| Q90499971 | Control of cytokine-driven eosinophil migratory behavior by TGF-beta-induced protein (TGFBI) and periostin |
| Q89621135 | Convergence of Inflammatory Pathways in Allergic Asthma and Sickle Cell Disease |
| Q92471880 | Creatine supplementation impairs airway inflammation in an experimental model of asthma involving P2 × 7 receptor |
| Q55079099 | Diabetes Downregulates Allergen-Induced Airway Inflammation in Mice. |
| Q98779284 | Elevated Levels of Activated and Pathogenic Eosinophils Characterize Moderate-Severe House Dust Mite Allergic Rhinitis |
| Q40046428 | Eosinophilic and Non-Eosinophilic Asthma. |
| Q92708716 | Eosinophils Affect Antibody Isotype Switching and May Partially Contribute to Early Vaccine-Induced Immunity against Coxiella burnetii |
| Q98177678 | Eosinophils and Purinergic Signaling in Health and Disease |
| Q55311740 | Eosinophils from Physiology to Disease: A Comprehensive Review. |
| Q90929373 | Group 2 innate lymphoid cells (ILC2) are regulated by stem cell factor during chronic asthmatic disease |
| Q50068947 | Human eosinophils and mast cells: Birds of a feather flock together |
| Q92514827 | Icariside II attenuates eosinophils-induced airway inflammation and remodeling via inactivation of NF-κB and STAT3 in an asthma mouse model |
| Q90190381 | In Vivo Allergen-Activated Eosinophils Promote Collagen I and Fibronectin Gene Expression in Airway Smooth Muscle Cells via TGF-β1 Signaling Pathway in Asthma |
| Q90259051 | Metabolic Profiling of Human Eosinophils |
| Q103001543 | Overexpression of corticotropin-releasing factor in intestinal mucosal eosinophils is associated with clinical severity in Diarrhea-Predominant Irritable Bowel Syndrome |
| Q90632499 | Peroxidasin and eosinophil peroxidase, but not myeloperoxidase, contribute to renal fibrosis in the murine unilateral ureteral obstruction model |
| Q92879746 | Potential Mechanisms of T Cell-Mediated and Eosinophil-Independent Bronchial Hyperresponsiveness |
| Q47661458 | Prophylactic benefits of systemically delivered simvastatin treatment in a house dust mite challenged murine model of allergic asthma |
| Q55347940 | Protective Effects of Casticin From Vitex trifolia Alleviate Eosinophilic Airway Inflammation and Oxidative Stress in a Murine Asthma Model. |
| Q96230030 | Remote allergen exposure elicits eosinophil infiltration into allergen nonexposed mucosal organs and primes for allergic inflammation |
| Q99609718 | Response to mepolizumab treatment is sustained across 4-weekly dosing periods |
| Q57191721 | Role of Matrix Metalloproteinase-2 in Eosinophil-Mediated Airway Remodeling |
| Q90187123 | Strongyloides stercoralis Infection in Solid Organ Transplant Patients is Associated with Eosinophil Activation and Intestinal Inflammation: A Cross-sectional Study |
| Q77789759 | Surface area- and mass-based comparison of fine and ultrafine nickel oxide lung toxicity and augmentation of allergic response in an ovalbumin asthma model |
| Q92825638 | The Enhanced Adhesion of Eosinophils Is Associated with Their Prolonged Viability and Pro-Proliferative Effect in Asthma |
| Q58795817 | The prostaglandin D receptor 2 pathway in asthma: a key player in airway inflammation |
| Q49333301 | Type 2 cytokine responses: regulating immunity to helminth parasites and allergic inflammation |
| Q48171121 | We Have to Learn to Do without Knowing Enough: Antieosinophilic Treatments for Severe Asthma |
| Q58116524 | [Vasculitides and eosinophilic pulmonary diseases] |
Search more.